TACI/TNFRSF13B/CVID Antibody, HRP, Novus Biologicals™
Manufacturer: Novus Biologicals
Select a Size
| Pack Size | SKU | Availability | Price |
|---|---|---|---|
| Each of 1 | NB195241-Each-of-1 | In Stock | ₹ 52,020.50 |
NB195241 - Each of 1
In Stock
Quantity
1
Base Price: ₹ 52,020.50
GST (18%): ₹ 9,363.69
Total Price: ₹ 61,384.19
Antigen
TACI/TNFRSF13B/CVID
Classification
Polyclonal
Formulation
PBS
Host Species
Rabbit
Purification Method
Peptide affinity purified
Regulatory Status
RUO
Primary or Secondary
Primary
Target Species
Human
Form
Purified
Applications
Western Blot, ELISA
Conjugate
HRP
Gene Alias
CD267, CD267 antigen, CVID, CVID2, FLJ39942, MGC133214, TACIMGC39952, TNFRSF14B, Transmembrane activator and CAML interactor, tumor necrosis factor receptor 13B, tumor necrosis factor receptor superfamily member 13B, tumor necrosis factor receptor superfamily, member 13B
Immunogen
Antibody was raised against a synthetic peptide mapping at the amino terminus of human TACI. The immunogen is located within the first 50 amino acids of TACI. Amino Acid Squence: SGLGRSRRGGRSRVD
Quantity
0.1 mL
Research Discipline
Apoptosis, B Cell Development and Differentiation Markers, Signal Transduction
Gene ID (Entrez)
23495
Content And Storage
Store at 4°C in the dark.
Isotype
IgG
Related Products
Description
- TACI/TNFRSF13B/CVID Polyclonal antibody specifically detects TACI/TNFRSF13B/CVID in Human samples
- It is validated for Western Blot, ELISA